PROTAC degrader inhibitor, ERD-308, Purity ≥98%

Synonym: 2320561-35-9; ERD308; ERD 308; (2S,4R)-1-[(2S)-2-[[2-[5-[Ethyl-[2-[4-[6-hydroxy-2-(4-hydroxyphenyl)-1-benzothiophene-3-carbonyl]phenoxy]ethyl]amino]pentoxy]acetyl]amino]-3,3-dimethylbutanoyl]-4-hydroxy-N-[(1S)-1-[4-(4-methyl-1,3-thiazol-5-yl)phenyl]ethyl]pyrrolidine-2-carboxamide; PROTAC degrader inhibitor

CAS Number: 2320561-35-9
Compound CID: 138454799

Product Size

5 mg; 10 mg; 50 mg; 100 mg

Price

Datasheet

Datasheet

MSDS

MSDS

Properties

Description

ERD-308 is an effective PROTAC inhibitor, that has the ability to prevent the pathway of PROTAC degrader. The molecular weight of the compound is 1004.26, and its molecular formula is C₅₅H₆₅N₅O₉S₂.

Molecular Weight

1004.26

Molecular Formula

C₅₅H₆₅N₅O₉S₂

Form

Lyophilized powder

Purity

≥98%

Impurities

Free from inappropriate visible particulates, foreign matter, discoloration, or other defects.

Identity

Confirmed by NMR/HPLC/MS.

Applications

ERD-308 can be studied extensively for its potential therapeutic applications in the treatment of breast cancer, particularly in cases where tumors develop resistance to traditional therapies like tamoxifen or aromatase inhibitors.